[HTML][HTML] The risk of COVID-19 pandemic in patients with moderate to severe plaque psoriasis receiving systemic treatments
… Nonetheless, caution should be maintained in this setting, and … Then, a retrospective
multicenter observational study … infections among patients treated with ustekinumab versus …
multicenter observational study … infections among patients treated with ustekinumab versus …
[HTML][HTML] Reversing the Inflammatory Process—25 Years of Tumor Necrosis Factor-α Inhibitors
KN Muth, J Rech, FO Losch, A Hoerning - Journal of Clinical Medicine, 2023 - mdpi.com
… In a retrospective study, this therapy regimen was shown to … to vedolizumab and ustekinumab
for achieving endoscopic … infections, such as tuberculosis or the hepatitis B virus. Thus, …
for achieving endoscopic … infections, such as tuberculosis or the hepatitis B virus. Thus, …
[HTML][HTML] Hepatitis B and C virus reactivations under biologic treatments in patients with rheumatic diseases: long-term results from a single-center
… infection before making a therapy option. These patients could … diseases undergoing anti-tumor
necrosis factor therapy or … arthritis: a retrospective multicenter Italian study. J Rheumatol …
necrosis factor therapy or … arthritis: a retrospective multicenter Italian study. J Rheumatol …
Long-term safety of approved biologics for ulcerative colitis
… An Italian retrospective study enrolling 107 patients showed … -23 in use for psoriasis and
psoriatic arthritis and approved for … The safety profile of vedolizumab and ustekinumab appears …
psoriatic arthritis and approved for … The safety profile of vedolizumab and ustekinumab appears …
[HTML][HTML] Liver-side of inflammatory bowel diseases: hepatobiliary and drug-induced disorders
S Mazza, S Soro, MC Verga, B Elvo… - World Journal of …, 2021 - ncbi.nlm.nih.gov
… Concomitant viral hepatitis B and C in IBD is also a relevant … studies, but two meta-analyses
and a large multicentre study … to 1.4% of patients during ustekinumab therapy. However, this …
and a large multicentre study … to 1.4% of patients during ustekinumab therapy. However, this …
Biologic treatment of 4 HIV-positive patients: a case series and literature review
B Myers, Q Thibodeaux, V Reddy… - Journal of Psoriasis …, 2021 - journals.sagepub.com
… retrospective review regarding the use of biologic therapy in … of severe plaque psoriasis and
chronic Hepatitis B and HIV … positive psoriasis patients successfully treated with ustekinumab…
chronic Hepatitis B and HIV … positive psoriasis patients successfully treated with ustekinumab…
[HTML][HTML] Long-term efficacy and safety of guselkumab in Chinese patients with moderate-to-severe plaque psoriasis
J Zheng, W Chen, X Yi, N Yu, Y Ding, Y Gao - Frontiers in Medicine, 2023 - ncbi.nlm.nih.gov
… hepatitis B virus or tuberculosis outbreak in these patients. … A total of nine (24.3%) patients
had failed anti-tumor necrosis factor-α (anti-… , and two (5.4%) had failed ustekinumab (Table 1). …
had failed anti-tumor necrosis factor-α (anti-… , and two (5.4%) had failed ustekinumab (Table 1). …
Safety of new biologics (vedolizumab and ustekinumab) and small molecules (tofacitinib) during pregnancy: a review
JP Gisbert, M Chaparro - Drugs, 2020 - Springer
… in pregnancy exists for anti-tumour necrosis factor (anti-TNF) … Although this retrospective
study did not include a control … However, the response to hepatitis B vaccination was similar in …
study did not include a control … However, the response to hepatitis B vaccination was similar in …
[HTML][HTML] Acute heart failure as an adverse event of tumor necrosis factor inhibitor therapy in inflammatory bowel disease: A review of the literature
TG Grillo, CFSM Pupo, AEV Quaglio… - World Journal of …, 2023 - ncbi.nlm.nih.gov
… Screening for hepatitis B and C viruses and HIV with serological … Ustekinumab, a monoclonal
antibody, is an option in … following anti-tumor necrosis factor alpha therapy in patients with …
antibody, is an option in … following anti-tumor necrosis factor alpha therapy in patients with …
Safety of systemic treatments for Behçet's syndrome
… Of note, TNF-α is able to control and remove hepatitis B virus (… A multicenter study on 124
BS patients showed the efficacy … was aimed to assess the efficacy and safety of ustekinumab in …
BS patients showed the efficacy … was aimed to assess the efficacy and safety of ustekinumab in …